278 Preclinical development of LYL119, a ROR1-targeted CAR T-cell product incorporating four novel T-cell reprogramming technologies to overcome barriers to effective cell therapy... by Lam, Viola C, Li, Aileen, Casas, Meritxell Galindo, Barragan, Jessica, Cheung, Christina, Briones, Jessica, Afreen, Esha, Vavra, Grant, Lu, Jia, Sundar, Purnima, Martinez, Rowena, Sims, Candace, Ta, Christina, Nigatu, Eskedar, Potluri, Shobha, Ali, Omar, Cheung, Alexander S, Lynn, Rachel C

Get full text